Asia-Pacific Malaria Treatment Market Size, Share, Growth, Trends, Analysis, & Forecast

The malaria treatment market is growing tremendously across Asia-Pacific due to the rise in medical insurance and additionally pandemic outbreak of coronavirus disease (COVID-19) across the globe. The various categories of the medication for malaria treatment include chloroquine, mefloquine, quinine, primaquine, hydroxychloroquine, artemisinin-based combination therapy (ACT), non-artemisinin based combinations (non-acts) and others. The presence of wide range of malaria medication treatment products is providing the better patient experience with reducing the risk of death. The increased research and development activities lead to the increased product launch by key market players of the malaria treatment market. However adverse effects and risks associated with anti-malaria may hamper the future growth of malaria treatment market